SUMMARY Results of supraphysiological adrenocorticotropic hormone (ACTH) stimulation of biosynthetic pathways of adrenal zona fasciculata indicate that a deficiency of 11-hydroxylase exists in patients with essential hypertension. The deficiency is suggested by the much greater stimulus of synthesis of deoxycorticosterone (DOC) and deoxycortisol in hypertensive subjects than in controls (p < 0.001). No significant difference in the synthesis of cortisol, corticosterone, progesterone, 17-hydroxyprogesterone (17-OHP), and delta-4-androstenedione (D4) was observed between the two groups. The ratios for synthesis of DOC and corticosterone and for deoxycortisol and cortisol found in hypertensive patients were significantly higher than those found in controls (p < 0.001); no significant difference was observed in the synthesis of 17-OHP and progesterone. The synthesis of DOC and deoxycortisol was not significantly correlated with either blood pressure or plasma renin activity. Plasma renin activity was significantly lower in hypertensive subjects than in normotensive subjects (p < 0.0O01), while no difference was found in aldosterone secretion between the two groups. The 11-hydroxylase deficiency in the adrenal zona fasciculata may be one of the genetic factors causing hypertension together with environmental factors (particularly salt intake and work-related stress). The investigation performed in our study may be useful for the evaluation of adrenal zona fasciculata enzymatic activities during the study of hypertensive patients. (Hypertension 7: 204-210, 1985) KEY WORDS • adrenal zona fasciculata • deoxycorticosterone • deoxycortisol plasma renin activity • aldosterone T HE possibility that adrenal steroids are involved in the pathogenesis of human essential hypertension is still under investigation. Mineralocorticoid activity often has been reported to be increased, especially in low-renin hypertension.'-2 Melby and colleagues 3 observed an increased excretion of 18-hydroxydeoxycorticosterone (18-OHDOC) in patients with low-renin hypertension who had marked responses to adrenocorticotropic-hormone-(ACTH)-inhibiting doses of dexamethasone. High plasma levels of 18-OHDOC also have been reported in patients with normal-renin hypertension. 4 The capability of deoxycorticosterone (DOC) to induce hyper- Received March 9, 1984; revision accepted September 24, 1984. tension has been demonstrated by McCall and coworkers 5 in rats treated with methylandrostenediol. Dexamethasone has also been used recently in hypertensive patients with excessive secretion of an unknown mineralocorticoid 6 and in a hypertensive girl with excessive secretion of urinary 17-ketosteroids. 7 Honda and colleagues 8 found abnormalities in the response of adrenal cortex to ACTH infusion in patients with normal-renin and low-renin hypertension that were compatible with a combined functional 17-hydroxylase and 11-hydroxylase failure. Wang and associates 9 have also found 17-hydroxylase deficiency in hypertensive patients. Alterations in excretion and metabolic clearance of several adrenal steroids have been reported by other authors.
T HE possibility that adrenal steroids are involved in the pathogenesis of human essential hypertension is still under investigation. Mineralocorticoid activity often has been reported to be increased, especially in low-renin hypertension.'- 2 Melby and colleagues 3 observed an increased excretion of 18-hydroxydeoxycorticosterone in patients with low-renin hypertension who had marked responses to adrenocorticotropic-hormone-(ACTH)-inhibiting doses of dexamethasone. High plasma levels of 18-OHDOC also have been reported in patients with normal-renin hypertension. 4 The capability of deoxycorticosterone (DOC) to induce hyper-tension has been demonstrated by McCall and coworkers 5 in rats treated with methylandrostenediol. Dexamethasone has also been used recently in hypertensive patients with excessive secretion of an unknown mineralocorticoid 6 and in a hypertensive girl with excessive secretion of urinary 17-ketosteroids. 7 Honda and colleagues 8 found abnormalities in the response of adrenal cortex to ACTH infusion in patients with normal-renin and low-renin hypertension that were compatible with a combined functional 17-hydroxylase and 11-hydroxylase failure. Wang and associates 9 have also found 17-hydroxylase deficiency in hypertensive patients. Alterations in excretion and metabolic clearance of several adrenal steroids have been reported by other authors. 10 -" These observations confirm the possibility that abnormalities in adrenal biosynthetic pathways, similar to those reported in congenital adrenal hyperplasia, may be involved in human essential hypertension. 12 -l3 In this study we evaluated the response of adrenal zona fasciculata to rapid injection of ACTH in patients with mild to moderate essential hypertension and in normotensive controls.
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Materials and Methods
Fifteen patients (6 women and 9 men), aged 19 to 59 (range, 44.7 ± 11.6 years), with mild to moderate essential hypertension (178.7 ± 15.9/108 ± 7.7 mm Hg; WHO grade I or II) and fifteen normotensive volunteers (5 women and 10 men), aged 22 to 59 (range, 42 ± 12 years), with no history of hypertension (131.33 ± 12.17/72.67 ± 5.63 mm Hg) were studied. All the subjects were Caucasian and came from a limited geographical area (the district of Naples). Persons with supposed or verified metabolic or endocrinological alterations, coronary heart disease, heart failure, or abnormal hepatic or renal function test results were excluded, as were all subjects with supine plasma aldosterone levels (measured after the subject awoke in the morning) of more than 150 pg/ml, with 17-ketosteroid or 11 -hydroxycorticoid urinary level alterations, and with uncertain responses to urography or renal radioisotopic angiography. No woman was pregnant. Informed consent was obtained from all subjects.
A fortnight's washout period was observed before the study. During this period all the subjects received a balanced, normocaloric diet without salt restriction.
The tests were carried out at 0900 to 1200 hours. The women were studied in the precocious follicular phase. No side effects were noted in any subject. Blood samples for baseline determinations of aldosterone and plasma renin activity (PRA) were drawn from the subjects after an overnight recumbency and 2 hours of fast walking. Plasma DOC, corticosterone, deoxycortisol, cortisol, progesterone, 17-hydroxyprogesterone (17-OHP), and delta-4-androstenedione (D4) levels were measured at baseline and 30, 60, 90, and 120 minutes after the rapid intravenous injection of 25 IU of a 1-24 polypeptidic fragment of ACTH (Synacthen). All subjects remained recumbent throughout.
Deoxycortisol and cortisol levels were measured by radioimmunoassay (antibody, Biodata s.p.a., Milan, Italy) after chromatography on a Sephadex LH20 column, 14 which also was used for separation of corticosterone. Corticosterone levels were measured by the method of proteic competition. Deoxycorticosterone levels were measured by proteic competition after chromatography on a Sephadex LH20 column. The 17-OHP levels were measured by radioimmunoassay (antibody, Biom6rieux, Charbonnieres-les-Bains, France) after extraction in ether. Delta-4-androstenedione and progesterone levels were measured by radioimmunoassay (antibody, Biome"rieux) after extraction in petroleum ether and chromatography on a Celite minicolumn (0.5 X 5 cm) adsorbed with methyleneglycol and ethyleneglycol, which were eluted with isooctane. The dosed values were corrected for the procedural loss by the pretreatment addition of 3000 d.p.m. to the serum of all the tritiated steroids.
The areas under curves of stimulus were examined to compare the responses of the steroids. Student's t test for impaired data and the analysis of variance with Neuman-Keuls's test of multiple comparison were employed to compare the mean values between groups.
Results
The age difference between hypertensive patients and controls was not significant. Mean values with statistical significance are shown in Table 1 . The areas of stimulus of DOC and deoxycortisol were significantly greater in hypertensive patients than in controls (p < 0.001). No significant difference was found in the areas of stimulus of cortisol, corticosterone, progesterone, 17-OHP, and D4. Baseline levels of DOC and deoxycortisol were significantly higher in hypertensive patients than in controls (p < 0.02) and were significantly correlated with their respective areas in both hypertensive and normotensive subjects ( Figures  1 and 2 ). The DOC/corticosterone and deoxycortisol/cortisol ratios found in hypertensive patients were significantly higher than those found in controls (p < 0.001). No significant difference between the groups was observed in the 17-OHP/progesterone ratio ( Table 1) .
The supine and upright PRA as well as its increase (the difference between upright and supine levels) was significantly lower in hypertensive patients than in NS NS DOC = deoxycorticosterone; S = deoxycortisol; B = corticosterone; F = cortisol; P = progesterone; 17-OHP = 17-hydroxyprogesterone; D4 = delta-4-androstenedione; PRA = plasma renin activity; NS = not significant. • g/WOml/itOmln.
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FIGURE 2. Correlation between the baseline values ofdeoxycortisol (S) and its areas of stimulus after supraphysiological stimulation with rapid injection of ACTH.
controls (p < 0.001; Figure 3 ), while no difference was found in plasma aldosterone levels between the two groups (Table 1) . Supine PRA, PRA increase, and mean, systolic, and diastolic blood pressures were not significantly correlated with the areas of DOC and deoxycortisol, the DOC/corticosterone ratio, and the deoxycortisol/cortisol ratio. The relationship between the areas of deoxycortisol and DOC ( Figure 4 ) and between deoxycortisol/cortisol ratio and DOC/corticosterone ratio was significant; the resulting r values were higher in the hypertensive group (p < 0.0001, r = 0.94; p < 0.0001, r = 0.98 respectively) than in controls (p < 0.001, r = 0.77; p < 0.005, r = 0.70 respectively; Table 2 ). The baseline PRA significantly correlated with its increase in both hypertensive (p < 0.01, r = 0.85) and normotensive (p < 0.001, r = 0.83; Table 2 ) groups. A significant correlation between age and baseline PRA occurred only in normotensive subjects (p < 0.05, r = -0.56; Table 2 ). The relationship between systolic and diastolic blood pressure and PRA (supine or increase) was not significant in either group.
Five subjects in the hypertensive group overlapped the normotensive group in some respects, such as deoxycortisol and DOC areas (Table 3 ). These subjects (Subgroup A) were compared with both the normotensive controls and with those in the hypertensive group who responded markedly to the tests (Subgroup B) (Neuman-Keuls's test; Table 4 ). The results in Subgroup A matched those of the normotensive group but were significantly different from those in Subgroup B in DOC (p < 0.001) and deoxycortisol (p < 0.001) areas and in DOC/corticosterone (p < 0.05) and de- 
KOmiOTEHSIVf

, .t'>00ml/imin
U0OO
FIGURE 4. Correlation betwen the areas of stimulus of deoxycortisol (S) and DOC in hypertensive and normotensive subjects.
oxycortisol/cortisol (p < 0.005) ratios. A significant difference in PRA was found between the normotensive group and both subgroups and between the two subgroups; the difference in Subgroup B was much larger (p < 0.0001) than that of Subgroup A (p < 0.05) when compared with controls (Table 4) .
Discussion
The ranges of the areas of stimulus of DOC and deoxycortisol and their significant correlation indicate that the activity 11-hydroxylase is impaired in our hypertensive patients. The 17-hydroxylating activity does not appear to be affected, as levels of 17-OHP and progesterone and 17-OHP/progesterone ratio were not significantly different in the two groups. Furthermore, the close correlations between the areas of stimulus of 
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•Significance between the two subgroups. tSignificance between Subgroups A or B and normal controls. DOC = deoxycorticosterone; S = deoxycortisol; B = corticosterone; F = cortisol; P = progesterone; 17-OHP 17-hydroxyprogesterone; D4 = delta-4-androstenedione; PRA = plasma renin activity; NS = not significant. DOC and deoxycortisol and between the DOC/corticosterone and deoxycortisol/cortisol ratios in the hypertensive group indicate that a deficiency of 17-hydroxylase is unlikely.
As the areas of stimulus of corticosterone and cortisol were similar in the two groups, the increase in the deoxycortisol/cortisol and DOC/corticosterone ratios in hypertensive patients appears to be caused only by the increases in deoxycortisol and DOC and shows an enzymatic deficiency that can be revealed by supraphysiological stimulation but that is not evident in a normal state.
The close correlation between the areas of DOC and deoxycortisol in the hypertensive group suggests that their response is due to the reduction of the same 11-hydroxylating system (Figure 4) . The functional deficiency of 11-hydroxylase observed in our patients appears to cause excessive formation of DOC and deoxycortisol, which may lead to hypertension and influence PRA because of sodium retention. Increased levels of known or unknown adrenal steroids seem to be found more frequently in low-renin hypertension 8 l5 and the adrenal enzymatic deficiencies may be more important than those in normal-renin hypertension.
We did not observe a negative correlation between the areas of DOC and deoxycortisol and either supine PRA or its increase. The lack of this correlation might be due to the influence of other variables on PRA. 16 " 19 The differences in PRA between the two studied groups might be due to the greater influence of adrenal steroids in hypertensive patients than in normotensive controls. Grim and Shade 20 have observed that DOC may markedly inhibit PRA. Although PRA appeared to be inhibited in the hypertensive subjects compared with its levels in normotensive volunteers, aldosterone secretion was not suppressed in these subjects. In fact, the values of aldosterone found in the hypertensive subjects were higher than what the PRA would indicate. Aldosterone has been shown to respond to administration of ACTH 21 and to take its rhythm. 22 The ACTH stimulation that is caused by enzymatic impairment may be more important than PRA in aldosterone formation in these patients and could act to support its levels. This action may be why aldosterone is reported within normal ranges in patients with essential hypertension. 23 The enzymatic activity of 11-hydroxylase of the zona glomerulosa may be normal in the hypertensive group. Normal 11-hydroxylase activity of the zona glomerulosa has been reported in patients with congenital adrenal hyperplasia 24 as well as in patients with low-renin primary hypertension. 23 We believe that the enzymatic deficiency found in the hypertensive group is genetically determined, as reinforced by frequent family history in patients with essential hypertension. This genetic tendency could involve the regulation of enzymatic activity rather than the structure of the gene itself, as reduced, but not absent, enzymatic activity was detected.
The influence of salt intake and stress in causing essential hypertension has been reported in several studies.
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tivities of adrenal zona fasciculata may be the catalyst for salt-intake and stress-related hypertension in many patients. Because of the enzymatic deficiency in hypertensive patients, salt intake cannot exert any control over the secretion of DOC and deoxycortisol in the adrenal zona fasciculata, which depends on cortisolregulated ACTH secretion; therefore, salt intake regulates the secretion of mineralocorticoids only in the adrenal zona glomerulosa, and not in the adrenal zona fasciculata. Stress-related hypertension 29 x may reveal the impaired enzymatic activity by stimulating corticotropin releasing factor formation and ACTH secretion, with consequent excessive production of DOC and deoxycortisol.
In our study the absence of correlation between blood pressure and the areas of both DOC and deoxycortisol might be due to the variable strengths exerted by environmental factors and age on the subjects' genetic tendency. On the contrary, in all the subjects we have injected the same dose of ACTH and have stimulated one of the most important responses to stress. We think that the environmental factors and the enzymatic deficiencies have an inverse relationship: the hypertensive disease is caused either by strong environmental factors acting on a slight enzymatic deficiency or by relatively weak environmental factors acting on a large degree of enzymatic deficiency. In congenital adrenal hyperplasia due to either 11-hydroxylase or 17-hydroxylase deficiencies, the enzymatic deficiency is complete and hypertension can develop even without the interference of environmental factors.
The incidence of the enzymatic deficiency in our hypertensive group was substantial (67%). The incidence in five patients in Subgroup A (33%) seemed to indicate that no alterations had occurred in the adrenal biosynthetic pathways. Therefore, the hypertensive disease in the latter group should be attributed to other so far poorly understood mechanisms. On the basis of standard selection of patients with primary hypertension, the five patients in Subgroup A would be considered homogeneous with the patients in Subgroup B. The evaluation of adrenal zona fasciculata enzymatic activities, however, shows that the two hypertensive subgroups are different.
Results of our study indicate that human essential hypertension is associated with abnormalities of adrenal enzymatic activities. This possibility should be considered during clinical investigations of hypertensive patients, when all other causes of disease have been excluded. The confirmation of a causal relationship between development of the disease and adrenal zona fasciculata enzymatic deficiency may provide new therapeutic insight and explain the mechanisms of some therapeutic tools (e.g., low salt diet, aldactone). Furthermore, the discovery of an enzymatic deficiency in hypertensive patients may reduce the epidemiological incidence of so-called primary hypertension.
